Last reviewed · How we verify
Estrogen receptor positive advanced or metastatic breast cancer
Approved treatments
- Orserdu · Stemline Therap
Orserdu works by blocking the estrogen receptor, a protein that helps cancer cells grow.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Estrogen receptor positive advanced or metastatic breast cancer patent landscape — cliff calendar, originator estates, attackable patents
- Estrogen receptor positive advanced or metastatic breast cancer treatment landscape brief
- Estrogen receptor positive advanced or metastatic breast cancer treatment updates RSS
Frequently asked questions about Estrogen receptor positive advanced or metastatic breast cancer
What drugs treat Estrogen receptor positive advanced or metastatic breast cancer?
Tracked treatments include Orserdu.
What is the treatment for Estrogen receptor positive advanced or metastatic breast cancer?
Standard treatment for Estrogen receptor positive advanced or metastatic breast cancer includes Orserdu. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Estrogen receptor positive advanced or metastatic breast cancer patent cliff · Estrogen receptor positive advanced or metastatic breast cancer CI report
- Treatment: Orserdu · Stemline Therap
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing